Corteva Inc (CTVA)
Official siteBASIC MATERIALS • AGRICULTURAL INPUTS • NYSE
Market Cap: $6.29B
Last updated: Nov 17, 2026 at 11:05 AM ET
Corteva Inc (CTVA) Financials: Revenue, Profit and Cash Flow
Corteva reported revenue of $17.40B for the fiscal year ended Dec 31, 2025, up 2.9% from the year before. That year, net income was $1.10B with a net margin of 6.4%, operating cash flow was $6.81B and free cash flow was $5.63B. The quarter ended Sep 30, 2026 had revenue of $2.46B and net income of -$568.00M.
Revenue and Margins
The operating margin was 14.0% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $14.04B, a compound annual rate of 2.4%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $17.40B | +2.9% | 47.3% | 14.0% | 6.4% |
| Dec 2024 | $16.91B | -1.8% | 43.6% | 10.7% | 5.4% |
| Dec 2023 | $17.23B | -1.3% | 42.4% | 10.3% | 4.3% |
| Dec 2022 | $17.45B | +11.5% | 40.2% | 9.0% | 6.6% |
| Dec 2021 | $15.65B | +10.1% | 41.1% | 6.6% | 11.3% |
| Dec 2020 | $14.22B | +2.7% | 40.2% | 3.6% | 4.9% |
| Dec 2019 | $13.85B | -3.1% | 38.1% | -2.8% | -6.8% |
| Dec 2018 | $14.29B | +0.3% | 30.4% | -46.5% | -35.2% |
| Dec 2017 | $14.24B | +1.4% | 41.0% | 1.3% | 17.8% |
| Dec 2016 | $14.04B | N/A | 40.2% | 6.3% | 3.6% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 19.7% from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.40B | $16.91B | $17.23B | $17.45B | $15.65B | $14.22B | $13.85B | $14.29B | $14.24B | $14.04B |
| Cost of revenue | $9.17B | $9.53B | $9.92B | $10.44B | $9.22B | $8.51B | $8.57B | $9.95B | $8.40B | $8.39B |
| Gross profit | $8.23B | $7.38B | $7.31B | $7.02B | $6.43B | $5.71B | $5.27B | $4.34B | $5.84B | $5.65B |
| Research and development | $1.47B | $1.40B | $1.34B | $1.22B | $1.19B | $1.14B | $1.15B | $1.35B | $1.51B | $1.51B |
| Operating income | $2.44B | $1.81B | $1.77B | $1.56B | $1.03B | $508.00M | -$382.00M | -$6.64B | $188.00M | $886.00M |
| Net income | $1.10B | $919.00M | $747.00M | $1.16B | $1.77B | $701.00M | -$941.00M | -$5.03B | $2.53B | $503.00M |
| EBITDA | $4.27B | $3.96B | $3.75B | $3.95B | $3.62B | $1.90B | $1.70B | -$1.97B | N/A | N/A |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.46B | $6.38B | $4.91B | $3.91B | $2.62B | $6.46B | $4.42B | $3.98B | $2.33B | $6.11B | $4.49B | $3.71B |
| Gross profit | $924.00M | $3.66B | $2.53B | $1.66B | $974.00M | $3.52B | $2.08B | $1.48B | $761.00M | $3.19B | $1.94B | $1.34B |
| Operating income | -$480.00M | $1.79B | $1.01B | $181.00M | -$301.00M | $1.75B | $805.00M | $129.00M | -$460.00M | $1.52B | $622.00M | -$167.00M |
| Net income | -$568.00M | $1.17B | $723.00M | -$549.00M | -$318.00M | $1.32B | $656.00M | -$39.00M | -$521.00M | $1.06B | $423.00M | -$251.00M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded total debt of $2.58B by $1.94B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $42.84B | $40.83B | $43.00B | $42.62B | $42.34B | $42.65B | $42.40B | $217.37B | $112.96B | $0 |
| Current assets | $17.34B | $15.10B | $16.26B | $16.80B | $15.55B | $14.77B | $13.52B | $45.94B | $23.05B | $0 |
| Cash and equivalents | $4.52B | $3.11B | $2.64B | $3.19B | $4.46B | $3.53B | $1.76B | $4.54B | $7.81B | $0 |
| Total liabilities | $18.46B | $16.80B | $17.72B | $17.08B | $16.72B | $17.59B | $17.84B | $67.06B | $38.03B | $0 |
| Short-term debt | $894.00M | $750.00M | $198.00M | $24.00M | $17.00M | $3.00M | $7.00M | $4.31B | $2.78B | $0 |
| Long-term debt | $1.69B | $1.95B | $2.29B | $1.28B | $1.10B | $1.10B | $115.00M | $11.57B | $18.00M | $0 |
| Shareholder equity | $24.14B | $23.79B | $25.04B | $25.30B | $25.38B | $24.82B | $24.31B | $149.56B | $74.76B | $0 |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $43.03B | $41.64B | $42.72B | $42.84B | $42.20B | $41.76B | $42.12B | $40.83B | $41.91B | $41.46B | $43.63B | $43.00B |
| Total liabilities | $18.29B | $16.24B | $18.11B | $18.46B | $16.74B | $15.61B | $17.60B | $16.80B | $16.93B | $16.04B | $18.62B | $17.72B |
| Cash and equivalents | $3.93B | $2.37B | $1.96B | $4.52B | $2.51B | $2.06B | $2.01B | $3.11B | $2.42B | $1.84B | $1.50B | $2.64B |
| Shareholder equity | $24.49B | $25.16B | $24.36B | $24.14B | $25.22B | $25.91B | $24.29B | $23.79B | $24.74B | $25.18B | $24.77B | $25.04B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 82.7% of operating cash flow. Dividends and share repurchases together came to 57.4% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $6.81B | $4.33B | $3.50B | $1.71B | $2.73B | $2.06B | $1.07B | $483.00M | $247.00M | $3.36B |
| Capital expenditures | $1.18B | $1.19B | $1.19B | $1.21B | $573.00M | $475.00M | $1.16B | $1.50B | $1.11B | $1.02B |
| Free cash flow | $5.63B | $3.14B | $2.31B | $501.00M | $2.15B | $1.59B | -$93.00M | -$1.02B | -$866.00M | $2.34B |
| Dividends paid | $2.16B | $2.34B | $439.00M | $418.00M | $397.00M | $448.00M | $511.00M | $2.81B | $988.00M | $1.33B |
| Share repurchases | $1.07B | $1.01B | $756.00M | $1.00B | $950.00M | $275.00M | $25.00M | $0 | N/A | N/A |
| Investing cash flow | -$1.09B | -$817.00M | -$3.99B | -$1.26B | -$362.00M | -$674.00M | -$904.00M | -$505.00M | $386.00M | -$1.51B |
| Financing cash flow | -$3.29B | -$2.80B | -$137.00M | -$2.33B | -$1.27B | $303.00M | -$2.93B | -$2.62B | $2.40B | -$2.38B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$1.18B | -$932.00M | -$5.78B | $8.75B | $386.00M | $1.89B | -$4.22B | $8.40B | $254.00M | $897.00M | -$5.22B | $6.10B |
| Capital expenditures | $302.00M | $244.00M | $162.00M | $444.00M | $314.00M | $236.00M | $188.00M | $362.00M | $308.00M | $228.00M | $296.00M | $778.00M |
| Free cash flow | -$1.48B | -$1.18B | -$5.94B | $8.31B | $72.00M | $1.66B | -$4.41B | $8.04B | -$54.00M | $669.00M | -$5.52B | $5.32B |
Frequently Asked Questions About CTVA
What is Corteva's annual revenue?
Corteva reported revenue of $17.40B for the fiscal year ended Dec 31, 2025.
How fast is Corteva's revenue growing?
Revenue was up 2.9% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -0.1%.
Is Corteva profitable?
Yes. Corteva reported net income of $1.10B for the fiscal year ended Dec 31, 2025, with a net margin of 6.4%.
How much free cash flow does CTVA generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $6.81B minus capital expenditures of $1.18B produced free cash flow of $5.63B.
How much debt does Corteva have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $1.69B, short-term debt of $894.00M and cash and equivalents of $4.52B.
CTVA pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors